NasdaqGS - Nasdaq Real Time Price • USD
Kamada Ltd. (KMDA)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 5:59 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 0.06 | 0.06 | 0.22 | 0.41 |
| Low Estimate | 0.05 | 0.05 | 0.18 | 0.25 |
| High Estimate | 0.07 | 0.07 | 0.27 | 0.58 |
| Year Ago EPS | -0.04 | 0.04 | 0.15 | 0.22 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 38.01M | 39.37M | 158.22M | 195.05M |
| Low Estimate | 37.51M | 39.25M | 158M | 175M |
| High Estimate | 38.5M | 39.5M | 158.44M | 215.11M |
| Year Ago Sales | 30.71M | 37.44M | 142.52M | 158.22M |
| Sales Growth (year/est) | 23.80% | 5.10% | 11.00% | 23.30% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.02 | 0.02 | 0.03 | 0.05 |
| EPS Actual | -0.04 | 0.04 | 0.06 | 0.09 |
| Difference | -0.06 | 0.02 | 0.03 | 0.04 |
| Surprise % | -300.00% | 100.00% | 100.00% | 80.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.06 | 0.06 | 0.22 | 0.41 |
| 7 Days Ago | 0.06 | 0.06 | 0.22 | 0.41 |
| 30 Days Ago | 0.06 | 0.06 | 0.22 | 0.41 |
| 60 Days Ago | 0 | 0 | 0.28 | 0.55 |
| 90 Days Ago | 0 | 0 | 0.28 | 0.55 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | KMDA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 250.00% | -- | -- | 1.50% |
| Next Qtr. | 50.00% | -- | -- | 11.40% |
| Current Year | 46.70% | -- | -- | 5.20% |
| Next Year | 86.40% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 6.00% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -27.29% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/17/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/25/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 3/16/2023 |
| Initiated | Chardan Capital: Buy | 2/2/2018 |
Related Tickers
LFCR Lifecore Biomedical, Inc.
6.33
-1.86%
EVO Evotec SE
5.23
-32.95%
AMRX Amneal Pharmaceuticals, Inc.
6.05
+12.04%
TARO Taro Pharmaceutical Industries Ltd.
42.20
-0.07%
RDHL RedHill Biopharma Ltd.
0.4199
-2.10%
HCM HUTCHMED (China) Limited
18.41
+0.88%
INCR InterCure Ltd.
2.6700
+3.49%
PBH Prestige Consumer Healthcare Inc.
70.13
-1.53%
RDY Dr. Reddy's Laboratories Limited
70.92
-0.80%
INDV Indivior PLC
18.81
+0.97%